Sec. 214. Support for research and development of bioindustrial manufacturing processes
886 words·~4 min read·
/bill/117/hr/7900/pcs/section-214A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subject to the availability of appropriations, the Secretary of Defense shall provide support to manufacturing innovation institutes for the research and development of innovative bioindustrial manufacturing processes and the development of a network of bioindustrial manufacturing facilities to improve the ability of the industrial base to use such processes for the production of chemicals, materials, and other products necessary to support national security or secure fragile supply chains. The support provided under subsection
(a)may consist of— the establishment of one or more manufacturing innovation institutes specializing in the research and development of bioindustrial manufacturing processes; providing funding to one or more existing manufacturing innovation institutes— to support the research and development of bioindustrial manufacturing processes; or to otherwise expand the bioindustrial manufacturing capabilities of such institutes; the establishment of dedicated facilities within one or more manufacturing innovation institutes to serve as regional hubs for the research, development, and the scaling of bioindustrial manufacturing processes and products to higher levels of production; or designating a manufacturing innovation institute to serve as the lead entity responsible for integrating a network of pilot and intermediate scale bioindustrial manufacturing facilities. A manufacturing innovation institute that receives support under subsection
(a)shall carry out activities relating to the research, development, test, and evaluation of innovative bioindustrial manufacturing processes and the scaling of bioindustrial manufacturing products to higher levels of production, which may include— research on the use of bioindustrial manufacturing to create materials such as polymers, coatings, resins, commodity chemicals, and other materials with fragile supply chains; demonstration projects to evaluate bioindustrial manufacturing processes and technologies; activities to scale bioindustrial manufacturing processes and products to higher levels of production; strategic planning for infrastructure and equipment investments for bioindustrial manufacturing of defense-related materials; analyses of bioindustrial manufactured products and validation of the application of biological material used as input to new and existing processes to aid in future investment strategies and the security of critical supply chains; the selection, construction, and operation of pilot and intermediate scale bioindustrial manufacturing facilities; development and management of a network of facilities to scale production of bioindustrial products; activities to address workforce needs in bioindustrial manufacturing; establishing an interoperable, secure, digital infrastructure for collaborative data exchange across entities in the bioindustrial manufacturing community, including government agencies, industry, and academia; developing and implementing digital tools, process security and assurance capabilities, cybersecurity protocols, and best practices for data storage, sharing and analysis; and such other activities as the Secretary of Defense determines appropriate. In determining the number, type, and location of manufacturing innovation institutes or facilities to support under subsection (a), the Secretary of Defense shall consider— how the institutes or facilities may complement each other by functioning as a together as a network; how to geographically distribute support to such institutes or facilities— to maximize access to biological material needed as an input to bioindustrial manufacturing processes; to leverage available industrial and academic expertise; to leverage relevant domestic infrastructure required to secure supply chains for chemicals and other materials; and to complement the capabilities of other manufacturing innovation institutes and similar facilities; and how the activities supported under this section can be coordinated with relevant activities of other departments and agencies of the Federal Government. Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense shall submit to the appropriate congressional committees and the National Security Commission on Emerging Biotechnology a plan for the implementation of this section that includes— a description of types, relative sizes, and locations of the manufacturing innovation institutes or facilities the Secretary intends to establish or support under this section; a general description of the focus of each institute or facility, including the types of bioindustrial manufacturing equipment, if any, that are expected to be procured for each such institute or facility; a general description of how the institutes and facilities will work as a network to maximize the diversity of bioindustrial products available to be produced by the network; an explanation of how the network will support the establishment and maintenance of the bioindustrial manufacturing industrial base; and an explanation of how the Secretary intends to ensure that bioindustrial manufacturing activities conducted under this section are modernized digitally, including through— the use of a data automation to represent processes and products as models and simulations; and the implementation of measures to address cybersecurity and process assurance concerns. Not later than 180 days after the date of the submittal of the plan under paragraph (1), and biannually thereafter for five years, the Secretary of Defense shall provide to the appropriate congressional committees a briefing on the progress toward the implementation of the plan. In this section: The term appropriate congressional committees means— the congressional defense committees; the Committee on Agriculture, Nutrition, and Forestry and the Committee on Commerce, Science, and Transportation of the Senate; and the Committee on Agriculture and the Committee on Science, Space, and Technology of the House of Representatives. The term bioindustrial manufacturing means the use of living organisms, cells, tissues, enzymes, or cell-free systems to produce materials and products for non-pharmaceutical applications. The term manufacturing innovation institute means a Manufacturing USA institute (as described in section 34(d) of the National Institute of Standards and Technology Act ( 15 U.S.C. 278s(d) )) that is funded by the Department of Defense.
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 214
Support for research and development of bioindustrial manufacturing processes
Cites 1Cited by 0 across 0 sources